Literature DB >> 8752128

Fimbria-fornix transections selectively down-regulate subtypes of glutamate transporter and glutamate receptor proteins in septum and hippocampus.

S D Ginsberg1, J D Rothstein, D L Price, L J Martin.   

Abstract

The effects of CNS axotomy on glutamate transporter and glutamate receptor expression were evaluated in adult rats following unilateral fimbria-fornix transections. The septum and hippocampus were collected at 3, 7, 14, and 30 days postlesion. Homogenates were immunoblotted by using antibodies directed against glutamate transporters (GLT-1, GLAST, and EAAC1) and glutamate receptors (GluR1, GluR2/3, GluR6/7, and NMDAR1), and they were assayed for glutamate transport by D-[3H]aspartate binding. GLT-1 was decreased at 7 and 14 days postlesion within the ipsilateral septum and at 7 days postlesion in the hippocampus. GLAST was decreased within the ipsilateral septum and hippocampus at 7 and 14 days postlesion. No postlesion alterations in EAAC1 immunoreactivity were observed. D-[3H]Aspartate binding was decreased at 7, 14, and 30 days postlesion within the ipsilateral septum and 14 days postlesion in the hippocampus. GluR2/3 expression was down-regulated at 30 days postlesion within the ipsilateral septum, whereas GluR1, GluR6/7, and NMDAR1 immunoreactivity was unchanged. In addition, no alterations in glutamate receptor expression were detected within hippocampal homogenates. This study demonstrates a selective down-regulation of primarily glial, and not neuronal, glutamate transporters and a delayed, subtype-specific down-regulation of septal GluR2/3 receptor expression after regional deafferentation within the CNS.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8752128     DOI: 10.1046/j.1471-4159.1996.67031208.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  16 in total

Review 1.  Inhibitory synaptic regulation of motoneurons: a new target of disease mechanisms in amyotrophic lateral sclerosis.

Authors:  Lee J Martin; Qing Chang
Journal:  Mol Neurobiol       Date:  2011-11-10       Impact factor: 5.590

2.  Differential regulation of catechol-O-methyltransferase expression in a mouse model of aggression.

Authors:  Stephen D Ginsberg; Shaoli Che; Audrey Hashim; Jiri Zavadil; Robert Cancro; Sang H Lee; Eva Petkova; Henry W Sershen; Jan Volavka
Journal:  Brain Struct Funct       Date:  2011-04-22       Impact factor: 3.270

Review 3.  Olesoxime, a cholesterol-like neuroprotectant for the potential treatment of amyotrophic lateral sclerosis.

Authors:  Lee J Martin
Journal:  IDrugs       Date:  2010-08

4.  The transcription factor Pax6 contributes to the induction of GLT-1 expression in astrocytes through an interaction with a distal enhancer element.

Authors:  Mausam Ghosh; Meredith Lane; Elizabeth Krizman; Rita Sattler; Jeffrey D Rothstein; Michael B Robinson
Journal:  J Neurochem       Date:  2015-11-24       Impact factor: 5.372

5.  Neuronal activity regulates glutamate transporter dynamics in developing astrocytes.

Authors:  Adrienne M Benediktsson; Glen S Marrs; Jian Cheng Tu; Paul F Worley; Jeffrey D Rothstein; Dwight E Bergles; Michael E Dailey
Journal:  Glia       Date:  2011-11-02       Impact factor: 7.452

6.  Induction of reactive astrocytosis and prevention of motoneuron cell death by the I(2)-imidazoline receptor ligand LSL 60101.

Authors:  A Casanovas; G Olmos; J Ribera; M A Boronat; J E Esquerda; J A García-Sevilla
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

7.  Unique anti-apoptotic activity of EAAC1 in injured motor neurons.

Authors:  Sumiko Kiryu-Seo; Kazushige Gamo; Taro Tachibana; Kohichi Tanaka; Hiroshi Kiyama
Journal:  EMBO J       Date:  2006-07-13       Impact factor: 11.598

8.  Focal loss of the glutamate transporter EAAT2 in a transgenic rat model of SOD1 mutant-mediated amyotrophic lateral sclerosis (ALS).

Authors:  David S Howland; Jian Liu; Yijin She; Beth Goad; Nicholas J Maragakis; Benjamin Kim; Jamie Erickson; John Kulik; Lisa DeVito; George Psaltis; Louis J DeGennaro; Don W Cleveland; Jeffrey D Rothstein
Journal:  Proc Natl Acad Sci U S A       Date:  2002-01-29       Impact factor: 11.205

9.  Nuclear factor-κB contributes to neuron-dependent induction of glutamate transporter-1 expression in astrocytes.

Authors:  Mausam Ghosh; Yongjie Yang; Jeffrey D Rothstein; Michael B Robinson
Journal:  J Neurosci       Date:  2011-06-22       Impact factor: 6.167

Review 10.  The role of glutamate transporters in neurodegenerative diseases and potential opportunities for intervention.

Authors:  Amanda L Sheldon; Michael B Robinson
Journal:  Neurochem Int       Date:  2007-04-19       Impact factor: 3.921

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.